USE OF MODIFIED AUTOGENOUS BLOOD FOR THE TREATMENT OF AUTOIMMUNE DISEASES.

摘要

AN AUTOIMMUNE VACCINE IS PROVIDED FOR ADMINISTRATION TO HUMAN PATIENTS, IN ORDER TO RELIEF THE SYMPTOMS OF AUTOIMMUNE DISEASES SUCH AS THE Rheumatoid ARTHRITIS. THE VACCINE INCLUDES AN ALICUOTA OF THE PATIENT'S BLOOD, CONTAINING, INTER ALIA, LEUKOCYTES WITH REGULATED EXPRESSION OF DIFFERENT MARKERS OF THE CELLULAR SURFACE AND LYMPHOCYTES CONTAINING REDUCED AMOUNTS OF CERTAIN PROTEINS. IT IS PRODUCED BY EXTRACORINGLY THE BLOOD ALICUOTA TO CERTAIN STRESSING, SPECIFICALLY OXIDIZING AGENTS, UV RADIATION AND HIGH TEMPERATURE.